Top section
Top section
UK follow-ons bring a secondary employee selldown and an increased primary capital raise
Helios's Moroccan health tech company T2S lists in Casablanca
Frédéric Despagne will also lead equity and derivatives sales across EMEA
More articles
More articles
More articles
-
UK biotech firms are continuing to reap the benefits from US listings. On Tuesday Autolus Therapeutics, an early stage biopharma firm backed by Syncona Investments, became the latest UK Biotech firm to raise capital on the US Nasdaq in a $100m transaction. The deal shows the continued advantages for early stage European biotech firms in having a US listing. -
IVC Evidensia, Europe’s largest veterinary care provider, backed by Swedish private equity firm EQT, has announced the results of a private equity capital raising on Tuesday. The company was reported to be considering a London listing this year, but this new raise might delay that listing.
-
Apollo Global Management has exited Watches of Switzerland, the UK luxury watch retailer, having sold the last of its shares via an accelerated bookbuild.
-
A blank cheque company fronted by Andrea Pignataro, the founder and executive chairman of trading software and financial data group ION, has listed on the Nasdaq, raising $300m.
-
Chinese cloud-based communications provider Cloopen Group Holdings saw its stock price triple on the first day of trading, after sealing a $320m IPO above the marketed range.
-
Banks that mostly missed out on last year's trading and origination windfall would find it difficult to make up for lost time by leaning into investment banking; that ship has probably already sailed.
Sub-sections
shared comment list
